参考文献/References:
[1] MANTRAVADI A V,VADHAR N.Glaucoma[J].Prim Care,2015,42(3):437-449.
[2] National institute for health and care excellence.Glaucoma:diagnosis and management[EB/OL].2017-11-01.https://www.nice.org.uk/guidance/ng81.
[3] YANG Y F,YU M B.Progress of anti-glaucoma fixed combination formulation[J].Chin J Ophthalmol,2011,47(2):109-114.
杨扬帆,余敏斌.青光眼固定配方复合制剂的发展和现状[J].中华眼科杂志,2011,47(2):109-114.
[4] SHARMA T,LOW S,FOSTER P J.The Classification of Primary Angle-Closure Glaucoma[M].Springer Heidelbery,2009:41-48.
[5] NOURI-MAHDAVI K,NIKKHOU K,HOFFMAN DC,LAW S K,CAPRIOLI J.Detection of early glaucoma with optical coherence tomography (StratusOCT)[J].J Glaucoma,2008,17(3):183-188.
[6] QUIGLEY H A,BROMAN A T.The number of people with glaucoma worldwide in 2010 and 2020[J].Br J Ophthalmol,2006,90(3):262-267.
[7] WANG J,CUI W.Progress in epidemiology of primary glaucomatous diseases in China[J].Int Eye Sci,2012,12(4):667-670.
汪俊,崔巍.我国原发性青光眼流行病学研究进展[J].国际眼科杂志,2012,12(4):667-670.
[8] ONG E P,CHENG J,DAMON W K,LIU J,ELTON L T,LEONARD W L.Glaucoma classification from retina optical coherence tomography angiogram[C]//International Conference of the IEEE Engineering in Medicine & Biology Society.Conf Proc IEEE Eng Med Biol Soc,2017:596-599.
[9] AGRAWAL A,SINGH A,MITTAL S K.Glaucoma in Asia- An epidemiological perspective[J].Nepal J Ophthalmol,2017,9(18):208-211.
[10] RAZEGHINEJAD M R,MYERS J S.Contemporary approach to the diagnosis and management of primary angle-closure disease[J].Surv Ophthalmol,2018,63(6):754-768.
[11] WANG Q L,FAN F G.Early diagnosis and curative effect analysis of primary open-angle glaucoma[J].Chin J Pharm Econ,2012,(2):47-48.
王清丽,樊飞虎.原发性开角型青光眼早期诊断及疗效分析[J].中国药物经济学,2012,(2):47-48.
[12] POLACZEK-KRUPA B,GRABSKA-LIBEREK I.Evaluation of the significance of some diagnostic parameters in making an early diagnose of primary open-angle glaucoma[J].Med Sci Monit,2012,18(7):456-460.
[13] ZHOU W.New trend of drug therapy for glaucoma[J].Mod Pract Med,2015,27(9):1122-1125.
周伟.青光眼药物治疗的新动向[J].现代实用医学,2015,27(9):1122-1125.
[14] PRUM B E,LIM M C,MANSBERGER S L,STEIN J D,MOROI S E;GEDDE S J,et al.Primary open-angle glaucoma suspect preferred practice pattern?Guidelines[J].Ophthalmology,2016,123(1):112-151.
[15] VARMA R,PEEPLES P,WALT,J G,BRAMLEY T J.Disease progression and the need for neuroprotection in glaucoma management[J].Am J Manag Care,2008,14(1 Suppl):s15-19.
[16] LI F,HUANG W B,ZHANG X L.Efficacy and safety of different regimens for primary open-angle glaucoma or ocular hypertension:asystematic review and network meta-analysis[J].Acta Ophthalmol,2018,96(3):277-284.
[17] WANG P,ZENG J H,TANG L.Analysis on the medication of the outpatients diagnosed with glaucoma at West China Hospital of Sichuan University[J].Chin J Ophthalmol,2018,54(3):189-193.
王培,曾继红,唐莉.四川大学华西医院门诊青光眼患者药物使用情况分析[J].中华眼科杂志,2018,54(3):189-193.
[18] ZHANG P,JIANG B.Individualized drug therapy for glaucoma[J].Rec Adv Ophthalmology,2010,30(10):991-993.
张谱,江冰.青光眼的个体化药物治疗[J].眼科新进展,2010,30(10):991-993.
[19] BERTELMANN E,MINKO N,TORUN N.Glaucoma attack following Hughes tarsoconjunctival flap:What should be done[J]?Ophthalmologe,2012,109(9):897-900.
[20] The Ophthalmology branch of Chinese Medical Association Ophthalmology clinical guideline[M].Beijing:People’s Health Publishing House,2013:103.
中华医学会眼科分会.眼科临床指南[M].北京:人民卫生出版社,2013:103.
[21] Glaucoma Section,Ophthalmology Branch,Chinese Medical Association.Glaucoma Section,Ophthalmology Branch,Chinese Medical Association[J].Chin J Ophthalmol,2014,50(5):382-383.
中华医学会眼科学分会青光眼学组.我国原发性青光眼诊断和治疗专家共识(2014年)[J].中华眼科杂志,2014,50(5):382-383.
[22] LAI J,CHOY B N,SHUM J W.Management of primary angle-closure glaucoma[J].Asia Pac J Ophthalmol,2016,5(1):59-62.
[23] LEE Y H,YUN Y M,KIM S H,LEE E K,LEE J E,KIM C S.Factors that influence intraocular pressure after cataract surgery in primary glaucoma[J].Can J Ophthalmol,2009,44(6):705-710.
[24] EISSA I M,ABU HUSSEIN N B,HABIB A E,EL SAYED Y M.Examining delay intervals in the diagnosis and treatment of primary open angle glaucoma in an egyptian population and its impact on lifestyle[J].J Ophthalmol,2016,2016:701-826.
相似文献/References:
[1]李翔 谢钊 郭红建 谢学军 路雪婧 王毅 王超.补肾活血中药对大鼠慢性高眼压模型外侧膝状体病理改变的影响[J].眼科新进展,2012,32(1):000.
[2]范虹 刘五存 蔡鸿英 赵堪兴.改良二极管激光睫状体光凝术治疗中晚期青光眼[J].眼科新进展,2012,32(4):000.
[3]王建萍 赵燕麟 马勇 朱涛 程燕 车选义 赵桂娥 王柯.噻吗洛尔和布林佐胺联合曲伏前列素治疗原发性开角型青光眼与高眼压患者的临床研究[J].眼科新进展,2012,32(5):000.
[4]杨红 阴正勤.眼球震颤的诊断与治疗研究进展[J].眼科新进展,2012,32(5):000.
[5]彭坤 靳隽 杨玉新 许银霞 王保君 闫义涛 杨华.长期联合应用噻吗洛尔对结膜组织炎性标记物ICAM-1和HLA-DR表达的影响[J].眼科新进展,2012,32(6):000.
[6]马恩普 赵小钊 董良 刘苏冰 曾照年.Healaflow在青光眼小梁切除术中的应用[J].眼科新进展,2012,32(6):000.
[7]王勇 叶应嘉 鲍先议 周龑丽 许荣 彭婷婷 曾志富.同轴微小切口超声乳化吸出术在青光眼滤过术后白内障摘出术中的应用[J].眼科新进展,2012,32(7):000.
[8]李翔 马世勇 李娟 王毅.补肾活血中药对大鼠慢性高眼压模型视神经病理改变的影响[J].眼科新进展,2013,33(2):000.
[9]史大领 王殿强.棘阿米巴性角膜炎的临床特点及诊断[J].眼科新进展,2013,33(6):000.
[10]白东娥 刘伟 季建.抗青光眼药物对青光眼患者泪液胰岛素水平的影响及其与眼表改变的关系[J].眼科新进展,2013,33(6):000.